Skip to main content

Table 3 Levels of 33 cytokines showing no significant difference between mild or moderately severe and severe acute pancreatitis a

From: Circulating cytokines in predicting development of severe acute pancreatitis

Cytokines

Mild or moderately severe AP (n= 138)

P- valueb

Severe AP (n= 25)

CTACK

993.1 (746.4 to 1,556.1)

0.033 (NS)

693.3 (652.5 to 1,150.6)

Eotaxinc

1 (0 to 1)

0.133 (NS)

1 (0 to 1)

FGF

25.9 (8.6 to 44.6)

0.123 (NS)

19.4 (0.4 to 35.2)

GM-CSFc

0 (0)

0.663 (NS)

0 (0 to 1)

IFN-γ

99.5 (50.7 to 151.0)

0.772 (NS)

82.4 (50.9 to 149.5)

IP-10

379.3 (244.5 to 594.0)

0.475 (NS)

446.2 (222.6 to 825.3)

IL-1αc

0 (0 to 1)

0.473 (NS)

1 (0 to 1)

IL-1β

1.9 (0.8 to 3.0)

0.961 (NS)

1.9 (0.5 to 3.4)

IL-1Ra

121.1 (64.8 to 260.0)

0.131 (NS)

202.6 (70.9 to 669.8)

IL-2

7.6 (2.2 to 13.4)

0.796 (NS)

6 to 7 (1.7 to 12.9)

IL-3c

0 (0)

0.008 (NS)

0 (0 to 1)

IL-4

5.1 (2.6 to 7.5)

0.261 (NS)

3.8 (2.3 to 6.4)

IL-5

2.7 (1.6 to 4.1)

0.091 (NS)

1.8 (1.0 to 3.4)

IL-7

5.9 (3.9 to 10.5)

0.482 (NS)

5.2 (3.9 to 9.4)

IL-9

19.5 (7.3 to 37.8)

0.410 (NS)

16.1 (1.7 to 38.7)

IL-10

8.2 (3.9 to 17.7)

0.012 (NS)

15.8 (6.2 to 42.3)

IL-12p70

18.7 (11.2 to 40.4)

0.442 (NS)

15.5 (9.0 to 36.5)

IL-12p40c

0 (0)

0.691 (NS)

0 (0)

IL-13

7.2 (3.9 to 13.5)

0.249 (NS)

6.5 (2.6 to 12.1)

IL-15c

0 (0)

0.018 (NS)

0 (0 to 1)

IL-16

220.2 (99.9 to 786.8)

0.120 (NS)

341.3 (157.2 to 980.1)

IL-17A

79.8 (33.2 to 155.9)

0.084 (NS)

45.8 (9.2 to 98.4)

MIP-1α

6.2 (3.7 to 8.0)

0.215 (NS)

4.6 (2.4 to 7.1)

MIP-1β

67.1 (42.6 to 90.2)

0.830 (NS)

63.6 (40.1 to 95.8)

MIF

695.8 (348.5 to 1,553.9)

0.004 (NS)

1461.2 (713.4 to 4,529.4)

MIG

1,415.5 (821.0 to 2,348.2)

0.021 (NS)

2,147.5 (1,257.4 to 4,268.7)

PDGF-BB

1,183.6 (360.4 to 2,475.2)

0.063 (NS)

583.3 (207.8 to 1,427.3)

RANTES

2,905.6 (1,110.3 to 4,511.1)

0.093 (NS)

1,877.2 (787.5 to 3,090.9)

SCGF-β

31452.4 (21610.3 to 46978.0)

0.004 (NS)

47129.9 (30743.1 to 56343.2)

TRAIL

57.4 (33.3 to 92.0)

0.042 (NS)

84.8 (51.8 to 122.7)

TNF-α

20.8 (10.3 to 31.9)

0.730 (NS)

18.2 (9.7 to 31.5)

TNF-βc

0 (0 to 1)

0.187 (NS)

0 (0)

VEGF

29.9 (17.7 to 71.1)

0.436 (NS)

23.6 (17.4 to 64.2)

  1. aAP, Acute pancreatitis; CTACK, Cutaneous T-cell attracting chemokine; FGF, Basic fibroblast growth factor; GM-CSF, Granulocyte-macrophage colony-stimulating factor; IFN, Interferon; IL, Interleukin; IL-1Ra, Interleukin 1 receptor antagonist; IP-10, Interferon-γ-induced protein 10; VEGF, vascular endothelial growth factor; MIF, Macrophage migration inhibitory factor; MIG, Monokine induced by interferon γ; MIP, Macrophage inflammatory protein; VEGF, vascular endothelial growth factor; PDGF-BB, Platelet-derived growth factor, two BB chains; RANTES, Regulated on activation, normal T cell expressed and secreted; SCGF-β, Stem cell growth factor β; TNF, Tumor necrosis factor; TRAIL, Tumor necrosis factor–related apoptosis-inducing ligand; VEGF, Vascular endothelial growth factor IQR, interquartile range; NS, Not significant. bLevel of significance is defined as P < 0.001 (Bonferroni-adjusted). c0 = Undetectable value, 1 = Detectable value. Data are median (IQR).